
Lenshil contains Lenvatinib 4mg, a targeted cancer medicine used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Generic Name | Lenvatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 10 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Availability | In Stock |




As a trusted supplier of high-quality generic anticancer medicines, we provide Lenshil (Lenvatinib 4mg) Capsules, widely prescribed for the treatment of thyroid cancer, liver cancer, and kidney cancers.
We offer safe, consistent, and timely bulk supply of oncology drugs, including Lenvatinib (Generic Lenvima), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers worldwide. Our global distribution network spans over 80 countries across Latin America, Africa, Asia, Europe, the Middle East, and North America, covering major markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.